NASDAQ:NSTG - NanoString Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $39.14
  • Forecasted Upside: 178.40 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$14.06
▼ -0.38 (-2.63%)

This chart shows the closing price for NSTG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New NanoString Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NSTG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NSTG

Analyst Price Target is $39.14
▲ +178.40% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for NanoString Technologies in the last 3 months. The average price target is $39.14, with a high forecast of $70.00 and a low forecast of $21.00. The average price target represents a 178.40% upside from the last price of $14.06.

This chart shows the closing price for NSTG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 polled investment analysts is to buy stock in NanoString Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/16/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/17/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/15/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/13/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/11/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/12/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/11/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/10/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/9/2022CowenLower Price Target$31.00Low
8/8/2022Morgan StanleyLower Price TargetEqual Weight$30.00 ➝ $28.00Low
8/5/2022Robert W. BairdLower Price Target$30.00 ➝ $21.00Low
7/19/2022CowenSet Price Target$33.00Low
5/11/2022Robert W. BairdLower Price Target$35.00 ➝ $30.00High
4/13/2022Canaccord Genuity GroupLower Price Target$50.00 ➝ $37.00High
4/13/2022CowenLower Price Target$65.00 ➝ $50.00High
4/13/2022Canaccord Genuity GroupLower Price TargetBuy$50.00 ➝ $37.00High
4/13/2022CowenLower Price Target$65.00 ➝ $50.00High
4/13/2022Robert W. BairdLower Price Target$51.00 ➝ $35.00High
3/24/2022Canaccord Genuity GroupInitiated CoverageBuy$50.00Medium
3/2/2022JPMorgan Chase & Co.Lower Price TargetOverweight$85.00 ➝ $70.00Medium
3/2/2022Robert W. BairdLower Price Target$60.00 ➝ $51.00High
11/10/2021Robert W. BairdLower Price TargetOutperform$71.00 ➝ $60.00High
10/14/2021CowenLower Price TargetOutperform$75.00 ➝ $65.00Medium
5/11/2021Morgan StanleyLower Price TargetEqual Weight$70.00 ➝ $65.00Low
3/3/2021Morgan StanleyBoost Price TargetEqual Weight$55.00 ➝ $70.00High
3/2/2021JPMorgan Chase & Co.Boost Price TargetOverweight$75.00 ➝ $80.00Medium
3/2/2021Robert W. BairdBoost Price TargetOutperform$70.00 ➝ $78.00Medium
1/11/2021Robert W. BairdBoost Price TargetOutperform$60.00 ➝ $70.00High
1/6/2021CowenUpgradeMarket Perform ➝ Outperform$75.00N/A
12/3/2020Morgan StanleyBoost Price TargetEqual Weight$44.00 ➝ $55.00Low
12/2/2020JPMorgan Chase & Co.Boost Price Target$45.00 ➝ $60.00Low
12/2/2020Robert W. BairdBoost Price TargetOutperform$33.00 ➝ $44.00High
9/9/2020Morgan StanleyInitiated CoverageEqual Weight$43.00High
8/11/2020UBS GroupBoost Price TargetBuy$38.00 ➝ $40.00High
5/11/2020Robert W. BairdBoost Price TargetOutperform$29.00 ➝ $34.00High
4/28/2020UBS GroupLower Price TargetBuy$40.00 ➝ $38.00High
4/7/2020Robert W. BairdLower Price TargetOutperform$35.00 ➝ $29.00Medium
4/2/2020Stifel NicolausLower Price TargetBuy$38.00 ➝ $35.00Low
11/14/2019Stifel NicolausInitiated CoverageBuy$28.00Low
3/8/2019JPMorgan Chase & Co.Reiterated RatingOverweight$35.00High
10/10/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $18.00High
10/9/2018UBS GroupInitiated CoverageBuy ➝ Buy$23.00High
9/13/2018JPMorgan Chase & Co.Boost Price TargetOverweight$20.00Low
9/11/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$15.00 ➝ $18.00High
7/13/2018Morgan StanleyBoost Price TargetEqual Weight$12.00 ➝ $16.00Low
6/4/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$13.00 ➝ $15.00Low
3/8/2018Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$13.00 ➝ $12.00Low
11/3/2017Robert W. BairdLower Price TargetOutperform$14.00 ➝ $12.00N/A
10/24/2017Robert W. BairdReiterated RatingBuy$14.00N/A
10/12/2017Robert W. BairdLower Price TargetOutperform$23.00 ➝ $19.00N/A
10/12/2017Janney Montgomery ScottDowngradeBuy ➝ NeutralN/A
10/12/2017CowenDowngradeOutperform ➝ Market PerformN/A
9/28/2017CowenReiterated RatingBuy$20.00Low
(Data available from 8/10/2017 forward)

News Sentiment Rating

0.07 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/12/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/11/2022
  • 1 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/13/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
4/12/2022
  • 2 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
5/12/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
6/11/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/11/2022
  • 2 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
8/10/2022

Current Sentiment

  • 2 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
NanoString Technologies logo
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.
Read More

Today's Range

Now: $14.06
Low: $13.45
High: $14.15

50 Day Range

MA: $13.58
Low: $11.57
High: $16.21

52 Week Range

Now: $14.06
Low: $11.12
High: $62.34

Volume

1,013,627 shs

Average Volume

770,939 shs

Market Capitalization

$653.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.92

Frequently Asked Questions

What sell-side analysts currently cover shares of NanoString Technologies?

The following equities research analysts have issued reports on NanoString Technologies in the last year: Canaccord Genuity Group Inc., Cowen Inc, Cowen Inc., JPMorgan Chase & Co., Morgan Stanley, Robert W. Baird, and StockNews.com.
View the latest analyst ratings for NSTG.

What is the current price target for NanoString Technologies?

7 Wall Street analysts have set twelve-month price targets for NanoString Technologies in the last year. Their average twelve-month price target is $39.14, suggesting a possible upside of 178.4%. JPMorgan Chase & Co. has the highest price target set, predicting NSTG will reach $70.00 in the next twelve months. Robert W. Baird has the lowest price target set, forecasting a price of $21.00 for NanoString Technologies in the next year.
View the latest price targets for NSTG.

What is the current consensus analyst rating for NanoString Technologies?

NanoString Technologies currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NSTG will outperform the market and that investors should add to their positions of NanoString Technologies.
View the latest ratings for NSTG.

What other companies compete with NanoString Technologies?

How do I contact NanoString Technologies' investor relations team?

NanoString Technologies' physical mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company's listed phone number is (888) 358-6266 and its investor relations email address is [email protected] The official website for NanoString Technologies is www.nanostring.com. Learn More about contacing NanoString Technologies investor relations.